[{"NetIncomeLoss_1_Q2_USD":-9255000.0,"OperatingLeaseExpense_1_Q2_USD":700000.0,"OperatingLeaseExpense_2_Q2_USD":1000000.0,"AssetsCurrent_0_Q2_USD":120121000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":2194000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-7650000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q2_pure":0.0044,"MarketableSecuritiesRealizedGainLoss_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.0166,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q2_pure":0.6818,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.6818,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":6560000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":297000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":31731628.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":106000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":31538329.0,"OtherNoncashIncomeExpense_2_Q2_USD":43000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":14979000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"OperatingLeaseRightOfUseAsset_0_Q2_USD":10991000.0,"ShareBasedCompensation_2_Q2_USD":3071000.0,"Assets_0_Q2_USD":145522000.0,"CommonStockSharesIssued_0_Q2_shares":31872122.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":67108000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":60313000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":1013000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":690000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":6477237.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":6477237.0,"ContractWithCustomerLiability_0_Q2_USD":29000000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":7705000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":2558000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_2_Q2_pure":0.25,"ProvisionForDoubtfulAccounts_1_Q2_USD":0.0,"OtherDeferredCostsNet_0_Q2_USD":3272000.0,"DepreciationDepletionAndAmortization_1_Q2_USD":1400000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":2113000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q2_USD":0.0,"NumberOfReportableSegments_2_Q2_Segment":1.0,"IncomeTaxExpenseBenefit_1_Q2_USD":4000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":34000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":2815000.0,"AccountsReceivableNetCurrent_0_Q2_USD":5375000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":9000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":16410000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":6465000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":12855000.0,"ClassOfWarrantOrRightOutstanding_0_Q2_shares":62096.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":938000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":1000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":1644000.0,"CostsAndExpenses_2_Q2_USD":57779000.0,"CostsAndExpenses_1_Q2_USD":28993000.0,"OperatingLeaseLiability_0_Q2_USD":11340000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":37000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":121000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_0_Q2_shares":0.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":128000.0,"Liabilities_0_Q2_USD":52399000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":251997000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":9233000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":25042000.0,"OtherAssetsNoncurrent_0_Q2_USD":1760000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-348000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-9222000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-18282000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-9255000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-18394000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":4.81,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":6.7,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":2047000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-396000.0,"LiabilitiesCurrent_0_Q2_USD":43037000.0,"CostOfRevenue_1_Q2_USD":14823000.0,"CostOfRevenue_2_Q2_USD":29945000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":31731628.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":31538329.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":3252000.0,"AccountsPayableCurrent_0_Q2_USD":7491000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-23997000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-9000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1822000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":3071000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-9251000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-18360000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":11600000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-4000.0,"InterestExpense_2_Q2_USD":2000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":2989000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.6174,"NetIncomeLoss_2_Q2_USD":-18394000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":12650000.0,"DividendsCommonStock_2_Q2_USD":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"OperatingLeasePayments_2_Q2_USD":800000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":631000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":631000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q2_pure":0.0036,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.0036,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":25042000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.107,"AccruedIncomeTaxesCurrent_0_Q2_USD":37000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":1644000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_Q2_USD":-1000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q2_pure":0.6758,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":10800000.0,"ShortTermInvestments_0_Q2_USD":80191000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":21500000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":2075000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":28952000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q2_pure":0.0,"InvestmentIncomeInterest_1_Q2_USD":246000.0,"InvestmentIncomeInterest_2_Q2_USD":756000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q2_USD":100000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":145522000.0,"OperatingIncomeLoss_1_Q2_USD":-9498000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_1_Q2_shares":0.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_2_Q2_shares":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":19495000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":38656000.0,"CommonStockValueOutstanding_0_Q2_USD":3000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"OperatingIncomeLoss_2_Q2_USD":-19123000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":3870000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":3071000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-30004000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-158983000.0,"DebtLongtermAndShorttermCombinedAmount_0_Q2_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":855000.0,"StockholdersEquity_0_Q2_USD":93123000.0,"OtherLiabilitiesCurrent_0_Q2_USD":283000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":129000.0,"ProfitLoss_2_Q2_USD":-18394000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.29,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.58,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":9800000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-797000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2107000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":12000000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1822000.0,"CommonStockSharesOutstanding_0_Q2_shares":31872122.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-7025000.0,"Ticker":"PSNL","CIK":"1527753","name":"PERSONALIS, INC.","OfficialName":"Personalis Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"307257592.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]